| CLASS | CHAL | LP7784-4 |
| COMPONENT | Aldosterone^2H post 25 mg captopril PO | LP304856-0 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Qn | LP7753-9 |
| parent | Aldosterone | Serum or Plasma | Chemistry - challenge | LP387099-7 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Observation | |
| EXAMPLE_UNITS | ng/dL | |
| EXAMPLE_UCUM_UNITS | ng/dL | |
| UNITSREQUIRED | Y | |
| STATUS | ACTIVE |
| LONG_COMMON_NAME | en-US | Aldosterone [Mass/volume] in Serum or Plasma --2 hours post 25 mg captopril PO |
| LONG_COMMON_NAME | en-US | Aldosterone [Mass/volume] in Serum or Plasma --2 hours post 25 mg captopril PO |
| SHORTNAME | en-US | Aldost 2h p 25 mg Cpl PO SerPl-mCnc |
| ConsumerName | en-US | Aldosterone 2 hr after 25 mg Captopril by mouth, Blood |
| SHORTNAME | es-AR | aldosterona^2 horas después de la administración de 25 mg de captropilo por vía oral:concentración de masa:punto en el tiempo:suero/plasma:cuantitativo: |
| SHORTNAME | pt-BR | Aldost 2H p 25 mg Cpl PO SerPl-mCnc |
| LONG_COMMON_NAME | nl-NL | Aldosteron^120 min na 25 mg captopril PO [massa/volume] in serum of plasma |
| LONG_COMMON_NAME | es-MX | Aldosterona : Suero o Plasma : Punto temporal: Concentración de masa: Cuantitativo: |
LOINC Version: 2.78